Latest Period
Q4 2025
Security Snapshot
Aptevo Therapeutics Inc. - Common Stock, par value $0.001 per share (APVO) Institutional Ownership
CUSIP: 03835L504
13F Institutional Holders and Ownership History from Q2 2025 to Q4 2025
Institutions Reporting
0
Shares (Excl. Options)
0
Price
$0.61
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Symbol
- APVO on Nasdaq
- Shares outstanding
- 3,295,607
- Price per share
- $0.61
- All holders as of 31 Dec 2025
- Q4 2025
- Total 13F shares
- 0
- Total reported value
- $0
- Share change
- -493,997
- Value change
- -$717,121
- Number of holders
- 0
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- APVO - Aptevo Therapeutics Inc. - Common Stock, par value $0.001 per share is tracked under CUSIP 03835L504.
- 0 institutions reported positions in Q4 2025.
- 4 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 12 to 0 between Q3 2025 and Q4 2025.
- Reported value moved from $717,121 to $0.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Source Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 0 institutions filings for Q4 2025.
Investment Quick Answers
What is CUSIP 03835L504?
CUSIP 03835L504 identifies APVO - Aptevo Therapeutics Inc. - Common Stock, par value $0.001 per share in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Continue With The Right Next Step
- Latest 13F filings - identify new institutional portfolio moves.
- Latest Schedule 13D/13G reports - cross-check beneficial ownership events.
- All institutional ownership pages - compare nearby CUSIPs and holder concentration.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 03835L504:
Significant Owners of Aptevo Therapeutics Inc. - Common Stock, par value $0.001 per share (APVO) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| YA II PN, Ltd. | 10% | $1,663,965 | 357,842 | YA II PN, Ltd. | 16 Jun 2025 | |||
| CVI Investments, Inc. | 9.9% | $1,073,526 | 357,842 | CVI Investments, Inc. | 30 Jun 2025 | |||
| L1 Capital Global Opportunities Master Fund, Ltd. | 5% | -50% | $492,900 | -$362,100 | 164,300 | -42% | L1 Capital Global Opportunities Master Fund, Ltd. | 14 Aug 2025 |
| BANK OF AMERICA CORP /DE/ | 0% | -100% | $125 | -$715,879 | 86 | -100% | BANK OF AMERICA CORP /DE/ | 31 Oct 2025 |
As of 31 Dec 2025, 0 institutional investors reported holding 0 shares of Aptevo Therapeutics Inc. - Common Stock, par value $0.001 per share (APVO). This represents 0% of the company’s total 3,295,607 outstanding shares.